Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Gordon Carl L bought 625,000 Blossomhill Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Gordon Carl L (Director) bought 625,000 Blossomhill Therapeutics, Inc. shares at US$16.00 for US$10M, leaving 2,714,279 shares. Filed Aug 12, 2026 (Form 4).
- Bought
- 625,000 shares
- Price
- US$16.00
- Value
- US$10M
- Holding after
- 2,714,279 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Conversion | 1,039,996 | 1,039,996 | Indirect | |
| Aug 10, 2026 | Common Stock | Conversion | 1,049,283 | 2,089,279 | Indirect | |
| Aug 10, 2026 | Common Stock | Buy | 625,000 | US$16.00 | 2,714,279 | Indirect |
Source
Related
- Blossomhill Therapeutics, Inc.
- Gordon Carl L
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Vivo Innovation Fund II Holdings, L.P. · Aug 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D · Chen Bihua · Aug 13, 2026
- Form 4 · OrbiMed Capital GP VIII LLC · Aug 12, 2026